Paper Details

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Faculty Members have conducted research related to the The Clinical Value of Metabolic Syndrome and Its Components With Respect to Sudden Cardiac Death Using Different Definitions: Two Decades of Follow-Up From the Tehran Lipid and Glucose Study

Mohammad Alidoosti

Mohammad Alidoosti

Professor of Cardiology

Department Cardiology

School of Medicine

Tehran Heart Center

Tehran University of Medical Sciences

Related Documents

1. Obstructive Sleep Apnea and Severity of Coronary Artery Disease, Caspian Journal of Internal Medicine (2018)

All Documents

1. Comparison of Machine-Learning Models for the Prediction of 1-Year Adverse Outcomes of Patients Undergoing Primary Percutaneous Coronary Intervention for Acute St-Elevation Myocardial Infarction, Clinical Cardiology (2024)

2. Comparative Outcomes of Percutaneous Transvenous Mitral Commissurotomy Between Low and High Wilkins Score, Asian Cardiovascular and Thoracic Annals (2023)

3. Impact of Dietary Advanced Glycation End-Product Restriction on Insulin Resistance and Anthropometric Indices in Coronary Artery Patients Treated With Percutaneous Coronary Intervention: A Randomized Controlled Trial, Journal of Tehran University Heart Center (2023)

4. In-Hospital and 1-Year Outcomes of Patients Without Modifiable Risk Factors Presenting With Acute Coronary Syndrome Undergoing Pci: A Sex-Stratified Analysis, Frontiers in Cardiovascular Medicine (2023)

5. In-Hospital and 1-Year Outcomes of Patients Without Modifiable Risk Factors Presenting With Acute Coronary Syndrome Undergoing Pci: A Sex-Stratified Analysis, Frontiers in Cardiovascular Medicine (2023)

6. The Relationship of Circulating Neuregulin 4 and Irisin, and Traditional and Novel Cardiometabolic Risk Factors With the Risk and Severity of Coronary Artery Disease, Cytokine (2023)

7. Comparison of Angiographic and Clinical Outcomes After Primary Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction Between Patients With and Without Concomitant Covid-19 Infection, Critical Pathways in Cardiology (2022)

8. Impact of Baseline Estimated Glomerular Filtration Rate Using Ckd-Epi Equation on Long-Term Prognosis of Stemi Patients: A Matter of Small Increments!, Critical Pathways in Cardiology (2022)

9. Outcome of Percutaneous Coronary Intervention in Old Patients Presenting With Acute Coronary Syndrome, Archives of Iranian Medicine (2022)

10. Preprocedural Colchicine in Patients With Acute St-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial (Podcast-Pci), Journal of Cardiovascular Pharmacology (2022)

11. Prognostic Implications of Calculated Apo-Lipoprotein B in Patients With St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcome Is Tied to Lower Cut-Points, Clinical Cardiology (2021)

12. A Right Atrial Appendage Thrombus Mimicking a Tumor, Journal of Cardiovascular Echography (2020)

13. Does Baseline Bun Have an Additive Effect on the Prediction of Mortality in Patients With Acute Pulmonary Embolism?, Journal of Tehran University Heart Center (2020)

14. One-Year Outcome of Patients With Coronary Artery Ectasia Undergoing Percutaneous Coronary Intervention: Clinical Implications and Question Marks, Journal of Tehran University Heart Center (2020)

15. Relationship Between the Severity of Coronary Artery Disease and Cardiovascular Risk Factors in Acute Coronary Syndrome: Based on Tehran Heart Center’S Data Registry, Journal of Tehran University Heart Center (2020)

16. Short-Term Safety and Long-Term Benefits of Stent Postdilation After Primary Percutaneous Coronary Intervention: Results of a Cohort Study, Catheterization and Cardiovascular Interventions (2020)

17. The Impact of a Dedicated Coronavirus Disease 2019 Primary Angioplasty Protocol on Time Components Related to St-Segment Elevation Myocardial Infarction Management in a 24/7 Primary Percutaneous Coronary Intervention–Capable Hospital, Kardiologia Polska (2020)

18. Twelve-Year History of Stemi Management in Tehran Heart Center: Concomitant Reduction of In-Hospital Mortality and Hospitalization Length, Archives of Iranian Medicine (2020)

19. A Large Congenital Ventricular Outpouching, Journal of Tehran University Heart Center (2019)

20. Association Between Vascular Endothelial Growth Factor Plasma Levels and Rs699947 Polymorphism and Coronary Collateral Vessel Formation, Journal of Tehran University Heart Center (2019)

21. Cha2ds2-Vasc Score As an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality After Primary Pci in Patients With Acute St Segment Elevation Myocardial Infarction, Medicina (Lithuania) (2019)

22. Does Invasive Treatment Increase the Long-Term Survival of St-Elevation Myocardial Infarction Patients With a History of Coronary Artery Bypass Graft Surgery?, Journal of Tehran University Heart Center (2019)

23. Effect of Age on Procedural Success, Complications, and Clinical Outcome From a Large Angioplasty Registry, Critical Pathways in Cardiology (2019)

24. Probable Simulation of Isolated Right Ventricular Myocardial Infarction by Anterior Myocardial Infarction, Journal of Tehran University Heart Center (2019)

25. Single Long Stents Versus Overlapping Multiple Stents in the Management of Very Long Coronary Lesions: Comparisons of Procedures and Clinical Outcomes, Journal of Tehran University Heart Center (2019)

26. Strategies to Reduce the Door-To-Device Time in St-Elevation Myocardial Infarction Patients, Journal of Tehran University Heart Center (2019)

27. Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With St-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (Pci) According to the 24/7 Primary Pci Service Registry in Iran: Protocol for a Cross-Sectional Study, JMIR Research Protocols (2019)

28. Angiographic Characteristics of St-Elevation Myocardial Infarction Patients With Infarct-Related Coronary Artery Ectasia Undergoing Primary Percutaneous Coronary Intervention, Critical Pathways in Cardiology (2018)

29. Catheter-Directed Thrombolysis in Acute Iliofemoral Deep Vein Thrombosis With or Without Stenting: A Case Series, Journal of Tehran University Heart Center (2018)

30. Comparing Serum Level of Vitamin D3 in Patients With Isolated Coronary Artery Ectasia and Normal Coronary Artery Individuals, Archives of Iranian Medicine (2018)

31. Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2018)

32. Obstructive Sleep Apnea and Severity of Coronary Artery Disease, Caspian Journal of Internal Medicine (2018)

33. Predictors of Long-Term Major Adverse Cardiac Events Following Percutaneous Coronary Intervention in the Elderly, Archives of Iranian Medicine (2018)

34. Predictors of Major Adverse Cardiac Events Following Elective Stenting of Large Coronary Arteries, Indian Heart Journal (2018)

35. Impact of Sex on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention, Critical Pathways in Cardiology (2017)

36. Nephroprotective Effects of L-Carnitine Against Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Open-Labeled Clinical Trial, Journal of Tehran University Heart Center (2017)

37. Biodegradable-Polymer Biolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study, Texas Heart Institute Journal (2016)

38. Comparing Clinical Outcomes for a Twelve-Month Trial of Zotarolimus- and Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Data From the Thcric Registry, Therapeutic Advances in Cardiovascular Disease (2016)

39. Comparison of 1-Year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein Iib/Iiia Inhibitors, Critical Pathways in Cardiology (2016)

40. Objectifying the Level of Incomplete Revascularization by the Residual Syntax Score and Evaluating Its Impact on the One-Year Outcome of Percutaneous Coronary Intervention in Patients With Multi-Vessel Disease, Cardiovascular Revascularization Medicine (2016)

41. One-Year Outcome of Everolimus-Eluting Stents Versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2016)

42. Preventive Effect of L-Carnitine and Its Derivatives on Endothelial Dysfunction and Platelet Aggregation, Clinical Nutrition ESPEN (2016)

43. A Risk-Scoring Model to Predict One-Year Major Adverse Cardiac Events After Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2015)

44. Relationship Between Body Mass Index and Outcome of Elective Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2015)

45. The Impact of Cytochrome P450 2C19 Polymorphism on the Occurrence of One-Year In-Stent Restenosis in Patients Who Underwent Percutaneous Coronary Intervention: A Case-Match Study, Anadolu Kardiyoloji Dergisi (2015)